Drug-nutrient interactions of folate

 Drug-nutrient interactions of folate

 Several folate antimetabolites are used clinically, as cancer chemotherapy (e.g., methotrexate), and as antibacterial (trimethoprim) and antimalarial (pyri-methamine) agents. Drugs such as trimethoprim and pyrimethamine act by inhibiting dihydrofolate reduc-tase, and they owe their clinical usefulness to a con-siderably higher affinity for the dihydrofolate reduc-tase of the target organism than the human enzyme; nevertheless, prolonged use can result in folate deficiency.

 

A number of anticonvulsants used in the treatment of epilepsy, including diphenylhydantoin (phenytoin), and sometimes phenobarbital and primidone, can also cause folate deficiency. Although overt megalo-blastic anemia affects only some 0.75% of treated epileptics, there is some degree of macrocytosis in 40%. The megaloblastosis responds to folic acid sup-plements, but in about 50% of such patients treated with relatively high supplements for 1–3 years there is an increase in the frequency of epileptic attacks.

Comments

Popular posts from this blog

Absorption, metabolism, and metabolic functions of pantothenic acid

Metabolic functions of vitamin B6

Orientation to human nutrition